BIND Biosciences, Inc. to Present at Upcoming 2013 Scientific Conferences  
3/6/2013 7:03:05 AM

BIND Biosciences, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called AccurinsTM, today announced presentations at two upcoming scientific conferences:

•Nanomedicines Alliance Industry Symposium, March 6-7, 2013, Rockville, MD ? BIND will provide an oral presentation entitled “Managing Scale-up Challenges for Nanomedicines” in a session discussing Nanomedicine Chemistry Manufacturing and Controls.